4th iPSC Drug Development and Manufacturing Summit
Evvnt Promotion / evvnt
Archivio
01.10.2024 - 03.10.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 08:00 - 17:00
Temi della conferenza
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder & Chief Scientific Officer, HebeCell, Anne Plant, Fellow Chief, Biosystems and Biomaterials Division, National Institute of Standards & Technology (NIST), and more
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder & Chief Scientific Officer, HebeCell, Anne Plant, Fellow Chief, Biosystems and Biomaterials Division, National Institute of Standards & Technology (NIST), and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2453698-2?pid=4832
Ms. Lara Chick
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
